Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact Of An Integrated Intervention Program On Adherence To Atorvastatin

NCT01078285 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.

NCT NCT01078285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact Of An Integrated Intervention Program On Adherence To Atorvastatin
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
November 30, 2011
Enrollment
500 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

medication non-adherence